Home › Funds › Invenomic Capital Management LP › CXT
Invenomic Capital Management LP position in CXT
CRANE NXT CO · Industrials
Invenomic Capital Management LP reported holding 233,914 shares of CXT (CRANE NXT CO) in its Q2 2026 13F filing — a position valued at US$12.0M, representing 0.71% of its reported portfolio and ranking #49 among its reported holdings. Invenomic Capital Management LP has disclosed CXT holdings in 6 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Invenomic Capital Management LP's CXT position evolved
Invenomic Capital Management LP first disclosed a stake in CXT in Q4 2024 at 139,888 shares (US$8.1M). The position peaked in Q2 2026 at 233,914 shares, worth US$12.0M. Across 6 filings, Invenomic Capital Management LP increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 233,914 shares valued at US$12.0M — an increase of 85,733 shares quarter over quarter.. Notable position changes include a 58% increase in Q2 2026 (shares fell 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 139.89K | $8.14M | New |
| Q1 2025 | 125.63K | $6.46M | Reduce |
| Q2 2025 | 128.89K | $6.95M | Add |
| Q4 2025 | 154.30K | $7.26M | New |
| Q1 2026 | 148.18K | $6.01M | Reduce |
| Q2 2026 | 233.91K | $11.97M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CXT and 13F data
CXT (CRANE NXT CO) is a Industrials company. 33 other funds we track also report a position in CXT — the largest reported positions include Channing Capital Management, LLC (US$102.1M), DEPRINCE RACE & ZOLLO INC (US$91.4M), SOUTHERNSUN ASSET MANAGEMENT, LLC (US$42.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CXT
- Channing Capital Management, LLC 2.00M sh · $102.08M · Q2 2026
- DEPRINCE RACE & ZOLLO INC 1.94M sh · $91.40M · Q3 2026
- SOUTHERNSUN ASSET MANAGEMENT, LLC 829.18K sh · $42.42M · Q2 2026
More on Invenomic Capital Management LP
FAQ
How long has Invenomic Capital Management LP held CXT?
Invenomic Capital Management LP has disclosed CXT holdings in 6 of the last 7 reported quarters, going back to Q4 2024.
What is Invenomic Capital Management LP's current position in CXT?
As of Q2 2026, Invenomic Capital Management LP holds 233.91K shares of CXT (CRANE NXT CO), valued at $11.97M, representing 0.71% of its reported portfolio and ranking #49.
Has Invenomic Capital Management LP been buying or selling CXT?
In the latest 13F filing (Q2 2026), Invenomic Capital Management LP increased its position in CXT. The position peaked in Q2 2026 at 233.91K shares.
Which other funds hold CXT?
Other major institutional holders of CXT include Channing Capital Management, LLC, DEPRINCE RACE & ZOLLO INC, SOUTHERNSUN ASSET MANAGEMENT, LLC, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.